volume 30 issue 12 pages 127199

Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells

Swayamsiddha Kar 1
Gayathri Ramamoorthy 2
Kartik Mitra 2
S. Naveen 3
Mahesha 4
Sai Kiran Mavileti 1
N. K. Lokanath 4
Mukesh Doble 2
Nageswara Rao Golakoti 1
Publication typeJournal Article
Publication date2020-06-01
scimago Q2
wos Q2
SJR0.472
CiteScore5.1
Impact factor2.2
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
Spirobibenzopyrans are an unexplored class of therapeutics. We report the anticancer activity of novel spirobibenzopyrans, synthesized by a one-pot reaction and extensively characterized. Structure of one of the spirobibenzopyran has been determined by the single crystal XRD technique. The in vitro anticancer activity of these derivatives across the NCI 60-cell line panel was evaluated and for the first time their mechanism of action against HeLa cells was probed via cell morphology analysis and cell cycle analysis. They were determined to be apoptosis inducers with cell cycle arrest in G0/G1 and S phase suggesting CDK-4 protein inhibition and the inhibition of DNA replication. The DNA inhibition was studied and confirmed using the alkaline comet assay for the compound CHX-4MO-SAL showing S phase inhibition. Further, conformity with the in silico Lipinski's score signify the potential of spirobibenzopyrans as anticancer leads.
Found 
Found 

Top-30

Journals

1
2
Journal of Molecular Structure
2 publications, 28.57%
Chemical Papers
1 publication, 14.29%
Organic and Biomolecular Chemistry
1 publication, 14.29%
Mendeleev Communications
1 publication, 14.29%
Molecules
1 publication, 14.29%
1
2

Publishers

1
2
Elsevier
2 publications, 28.57%
Springer Nature
1 publication, 14.29%
Royal Society of Chemistry (RSC)
1 publication, 14.29%
Federal Medical Biological Agency
1 publication, 14.29%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 14.29%
MDPI
1 publication, 14.29%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
7
Share
Cite this
GOST |
Cite this
GOST Copy
Kar S. et al. Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells // Bioorganic and Medicinal Chemistry Letters. 2020. Vol. 30. No. 12. p. 127199.
GOST all authors (up to 50) Copy
Kar S., Ramamoorthy G., Mitra K., Naveen S., Mahesha, Mavileti S. K., Lokanath N. K., Doble M., Golakoti N. R. Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells // Bioorganic and Medicinal Chemistry Letters. 2020. Vol. 30. No. 12. p. 127199.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmcl.2020.127199
UR - https://doi.org/10.1016/j.bmcl.2020.127199
TI - Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Kar, Swayamsiddha
AU - Ramamoorthy, Gayathri
AU - Mitra, Kartik
AU - Naveen, S.
AU - Mahesha
AU - Mavileti, Sai Kiran
AU - Lokanath, N. K.
AU - Doble, Mukesh
AU - Golakoti, Nageswara Rao
PY - 2020
DA - 2020/06/01
PB - Elsevier
SP - 127199
IS - 12
VL - 30
PMID - 32331934
SN - 0960-894X
SN - 1464-3405
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Kar,
author = {Swayamsiddha Kar and Gayathri Ramamoorthy and Kartik Mitra and S. Naveen and Mahesha and Sai Kiran Mavileti and N. K. Lokanath and Mukesh Doble and Nageswara Rao Golakoti},
title = {Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2020},
volume = {30},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016/j.bmcl.2020.127199},
number = {12},
pages = {127199},
doi = {10.1016/j.bmcl.2020.127199}
}
MLA
Cite this
MLA Copy
Kar, Swayamsiddha, et al. “Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells.” Bioorganic and Medicinal Chemistry Letters, vol. 30, no. 12, Jun. 2020, p. 127199. https://doi.org/10.1016/j.bmcl.2020.127199.